CYTH - Cyclo Therapeutics GAAP EPS of -$0.41 beats by $0.12 revenue of $0.54M misses by $0.08M August, 16 2022 08:41 AM Cyclo Therapeutics Inc. Cyclo Therapeutics press release ( NASDAQ: CYTH ): Q2 GAAP EPS of -$0.41 beats by $0.12 . Revenue of $0.54M (+125.0% Y/Y) misses by $0.08M . For further details see: Cyclo Therapeutics GAAP EPS of -$0.41 beats by $0.12, revenue of $0.54M misses by $0.08M